Lunai Bioworks Inc (LNAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -178,008 | -88,426 | -39,684 | -113,433 | -26,724 |
| Depreciation Amortization | 170,581 | 54,954 | 19,422 | 93,674 | 420 |
| Accounts payable and accrued liabilities | 3,106 | 4,057 | 3,895 | 1,081 | -272 |
| Other Working Capital | 5,860 | 8,812 | 4,305 | 1,415 | 1,200 |
| Other Operating Activity | -9,414 | 9,632 | 287 | 1,531 | 4,765 |
| Operating Cash Flow | $-7,875 | $-10,971 | $-11,775 | $-15,732 | $-20,611 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -70 | -30 | -5 | -49 |
| Net Acquisitions | N/A | 66 | N/A | N/A | N/A |
| Sale Of Investment | -500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,256 | 0 | 0 | 0 |
| Investing Cash Flow | $-500 | $-1,260 | $-30 | $-5 | $-49 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 6,978 | 8,046 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 342 | 5,637 | 4,806 | 1,303 |
| Other Financing Activity | 1,405 | 2,130 | -1,122 | -556 | 31,298 |
| Financing Cash Flow | $8,383 | $10,518 | $4,515 | $4,251 | $32,602 |
| Exchange Rate Effect | -136 | 60 | -8 | -5 | 26 |
| Beginning Cash Position | 221 | 1,875 | 9,172 | 20,664 | 8,696 |
| End Cash Position | 93 | 221 | 1,875 | 9,172 | 20,664 |
| Net Cash Flow | $-128 | $-1,654 | $-7,298 | $-11,492 | $11,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,875 | -10,971 | -11,775 | -15,732 | -20,611 |
| Capital Expenditure | N/A | -70 | -30 | -5 | -49 |
| Free Cash Flow | -7,875 | -11,042 | -11,804 | -15,738 | -20,660 |